Novel diagnostic and therapeutic approaches to pulmonary hypertension due to the unilateral absence of a pulmonary artery
暂无分享,去创建一个
A. Goda | T. Satoh | T. Kohno | H. Machida | K. Soejima | K. Takeuchi | J. Ito | H. Kikuchi | T. Inami | Toshiya Kariyasu | Yuki Nagamatsu
[1] K. Fukuda,et al. Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension , 2021, Therapeutic advances in respiratory disease.
[2] R. Thachathodiyl,et al. A Case Series of Young Patients with Completely Reversed Severe Pulmonary Hypertension. , 2017, Journal of clinical and diagnostic research : JCDR.
[3] M. Humbert,et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study , 2014, European Respiratory Journal.
[4] H. Ghanbari,et al. Unilateral absence of a left pulmonary artery: successful therapeutic response to a combination of bosentan and warfarin. , 2009, Circulation. Cardiovascular imaging.
[5] B. Siassi,et al. Isolated unilateral absence of the pulmonary artery. Review of the world literature and guidelines for surgical repair. , 1978, Japanese heart journal.
[6] R. Bahler,et al. Absent right pulmonary artery. Problems in diagnosis and management. , 1969, The American journal of medicine.
[7] E. Doyle,et al. Absence of a Primary Division of the Pulmonary Trunk: An Ontogenetic Theory , 1964, Circulation.
[8] J. Vogel,et al. Congenital unilateral absence of a pulmonary artery. The importance of flow in pulmonary hypertension. , 1962, The American journal of cardiology.